Literature DB >> 22893399

The BB rat as a model of human type 1 diabetes.

Rita Bortell1, Chaoxing Yang.   

Abstract

The BB rat is an important rodent model of human type 1 diabetes (T1D) and has been used to study mechanisms of diabetes pathogenesis as well as to investigate potential intervention therapies for clinical trials. The Diabetes-Prone BB (BBDP) rat spontaneously develops autoimmune T1D between 50 and 90 days of age. The Diabetes-Resistant BB (BBDR) rat has similar diabetes-susceptible genes as the BBDP, but does not become diabetic in viral antibody-free conditions. However, the BBDR rat can be induced to develop T1D in response to certain treatments such as regulatory T cell (T(reg)) depletion, toll-like receptor ligation, or virus infection. These diabetes-inducible rats develop hyperglycemia under well-controlled circumstances and within a short, predictable time frame (14-21 days), thus facilitating their utility for investigations of specific stages of diabetes development. Therefore, these rat strains are invaluable models for studying autoimmune diabetes and the role of environmental factors in its development, of particular importance due to the influx of studies associating virus infection and human T1D.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893399     DOI: 10.1007/978-1-62703-068-7_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

Review 1.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

2.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

Review 3.  Is a β cell a β cell?

Authors:  Chaoxing Yang; Feorillo Galivo; Craig Dorrell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

Review 4.  Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".

Authors:  Sally C Kent; Stuart I Mannering; Aaron W Michels; Jenny Aurielle B Babon
Journal:  Curr Diab Rep       Date:  2017-09-02       Impact factor: 4.810

5.  The effect of insulin dependent diabetes on bone metabolism and growth after spinal fusion.

Authors:  Zachary NaPier; Linda E A Kanim; Trevor J Nelson; Khosrowdad Salehi; Yasaman Arabi; Juliane D Glaeser; Dmitriy Sheyn; Melodie F Metzger
Journal:  Spine J       Date:  2019-11-20       Impact factor: 4.166

Review 6.  Can exposure to environmental chemicals increase the risk of diabetes type 1 development?

Authors:  Johanna Bodin; Lars Christian Stene; Unni Cecilie Nygaard
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

7.  End Sequence Analysis Toolkit (ESAT) expands the extractable information from single-cell RNA-seq data.

Authors:  Alan Derr; Chaoxing Yang; Rapolas Zilionis; Alexey Sergushichev; David M Blodgett; Sambra Redick; Rita Bortell; Jeremy Luban; David M Harlan; Sebastian Kadener; Dale L Greiner; Allon Klein; Maxim N Artyomov; Manuel Garber
Journal:  Genome Res       Date:  2016-07-28       Impact factor: 9.043

8.  Variations in rodent models of type 1 diabetes: islet morphology.

Authors:  Lesya Novikova; Irina V Smirnova; Sonia Rawal; Abby L Dotson; Stephen H Benedict; Lisa Stehno-Bittel
Journal:  J Diabetes Res       Date:  2013-05-13       Impact factor: 4.011

9.  Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.

Authors:  Negar Karimian; Tairan Qin; Tao Liang; Mayowa Osundiji; Yachi Huang; Trevor Teich; Michael C Riddell; Mark S Cattral; David H Coy; Mladen Vranic; Herbert Y Gaisano
Journal:  Diabetes       Date:  2013-04-29       Impact factor: 9.461

10.  Salicylate prevents virus-induced type 1 diabetes in the BBDR rat.

Authors:  Chaoxing Yang; Agata Jurczyk; Philip diIorio; Elaine Norowski; Michael A Brehm; Christian W Grant; Dennis L Guberski; Dale L Greiner; Rita Bortell
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.